| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |